Quantbot Technologies LP Atea Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$3.09 - $4.56 $4,017 - $5,927	1,300 Added 18.0%	8,522 $34,000
Q3 2023 Nov 07, 2023	SELL	$3.0 - $3.79 $18,600 - $23,498	-6,200 Reduced 46.19%	7,222 $21,000
Q2 2023 Aug 08, 2023	BUY	$3.21 - $5.06 $3,405 - $5,368	1,061 Added 8.58%	13,422 $50,000
Q1 2023 May 12, 2023	BUY	$3.0 - $4.97 $25,680 - $42,543	8,560 Added 225.2%	12,361 $41,000
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.17 $15,468 - $21,940	3,556 Added 1451.43%	3,801 $18,000
Q3 2022 Nov 07, 2022	SELL	$5.49 - $8.79 $8,031 - $12,859	-1,463 Reduced 85.66%	245 $1,000
Q2 2022 Aug 09, 2022	BUY	$5.33 - $8.18 $9,103 - $13,971	1,708 New	1,708 $12,000
Q1 2022 May 16, 2022	SELL	$5.5 - $9.19 $18,221 - $30,446	-3,313 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$7.67 - $44.59 $19,274 - $112,054	2,513 Added 314.13%	3,313 $29,000
Q3 2021 Nov 09, 2021	BUY	$21.33 - $35.06 $17,064 - $28,048	800 New	800 $28,000

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $270M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.